Thymidine Phosphorylase Participates in Platelet Signaling and Promotes Thrombosis

Rationale: Platelets contain abundant thymidine phosphorylase (TYMP), which is highly expressed in diseases with high risk of thrombosis, such as atherosclerosis and type II diabetes mellitus. Objective: To test the hypothesis that TYMP participates in platelet signaling and promotes thrombosis. Methods and Results: By using a ferric chloride (FeCl3)–induced carotid artery injury thrombosis model, we found time to blood flow cessation was significantly prolonged in Tymp−/− and Tymp+/− mice compared with wild-type mice. Bone marrow transplantation and platelet transfusion studies demonstrated that platelet TYMP was responsible for the antithrombotic phenomenon in the TYMP-deficient mice. Collagen-, collagen-related peptide–, adenosine diphosphate-, or thrombin-induced platelet aggregation were significantly attenuated in Tymp+/− and Tymp−/− platelets, and in wild type or human platelets pretreated with TYMP inhibitor KIN59. Tymp deficiency also significantly decreased agonist-induced P-selectin expression. TYMP contains an N-terminal SH3 domain-binding proline-rich motif and forms a complex with the tyrosine kinases Lyn, Fyn, and Yes in platelets. TYMP-associated Lyn was inactive in resting platelets, and TYMP trapped and diminished active Lyn after collagen stimulation. Tymp/Lyn double haploinsufficiency diminished the antithrombotic phenotype of Tymp+/− mice. TYMP deletion or inhibition of TYMP with KIN59 dramatically increased platelet-endothelial cell adhesion molecule 1 tyrosine phosphorylation and diminished collagen-related peptide– or collagen-induced AKT phosphorylation. In vivo administration of KIN59 significantly inhibited FeCl3-induced carotid artery thrombosis without affecting hemostasis. Conclusions: TYMP participates in multiple platelet signaling pathways and regulates platelet activation and thrombosis. Targeting TYMP might be a novel antiplatelet and antithrombosis therapy.

[1]  T. Sage,et al.  Antithrombotic actions of statins involve PECAM-1 signaling. , 2013, Blood.

[2]  W. Dunn,et al.  Autocrine amplification of integrin αIIbβ3 activation and platelet adhesive responses by deoxyribose-1-phosphate , 2013, Thrombosis and Haemostasis.

[3]  R. Silverstein,et al.  Ferric chloride-induced murine carotid arterial injury: A model of redox pathology☆ , 2013, Redox biology.

[4]  M. Ieko,et al.  APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica‐based reagent , 2012, Journal of thrombosis and haemostasis : JTH.

[5]  Lennart Martens,et al.  The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. , 2012, Blood.

[6]  S. Watson,et al.  Distinct and overlapping functional roles of Src family kinases in mouse platelets , 2012, Journal of thrombosis and haemostasis : JTH.

[7]  T. Furukawa,et al.  Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3. , 2012, Biochimica et biophysica acta.

[8]  E. Ingley.  Functions of the Lyn tyrosine kinase in health and disease , 2012, Cell Communication and Signaling.

[9]  D. Ribatti,et al.  The Thymidine Phosphorylase Inhibitor 5′-O-Tritylinosine (KIN59) Is an Antiangiogenic Multitarget Fibroblast Growth Factor-2 Antagonist , 2012, Molecular Cancer Therapeutics.

[10]  Lee-Jun C Wong,et al.  Detection of uniparental isodisomy in autosomal recessive mitochondrial DNA depletion syndrome by high-density SNP array analysis , 2011, Journal of Human Genetics.

[11]  I. Hagedorn,et al.  Genetic and antibody‐induced glycoprotein VI deficiency equally protects mice from mechanically and FeCl3‐induced thrombosis , 2011, Journal of thrombosis and haemostasis : JTH.

[12]  J. Major,et al.  Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state. , 2011, Blood.

[13]  P. Newman,et al.  Lyn and PECAM-1 function as interdependent inhibitors of platelet aggregation. , 2011, Blood.

[14]  Enas A. Hamed,et al.  Vasculopathy in type 2 diabetes mellitus: role of specific angiogenic modulators , 2011, Journal of Physiology and Biochemistry.

[15]  Natasha E. Barrett,et al.  Platelet endothelial cell adhesion molecule-1 regulates collagen-stimulated platelet function by modulating the association of phosphatidylinositol 3-kinase with Grb-2-associated binding protein-1 and linker for activation of T cells , 2010, Journal of thrombosis and haemostasis : JTH.

[16]  Aleksandra Stojanovic,et al.  An Important Role of the Src Family Kinase Lyn in Stimulating Platelet Granule Secretion* , 2010, The Journal of Biological Chemistry.

[17]  S. Diamond,et al.  Molecular priming of Lyn by GPVI enables an immune receptor to adopt a hemostatic role , 2009, Proceedings of the National Academy of Sciences of the United States of America.

[18]  F. Gago,et al.  Identification of aspartic acid-203 in human thymidine phosphorylase as an important residue for both catalysis and non-competitive inhibition by the small molecule "crystallization chaperone" 5'-O-tritylinosine (KIN59). , 2009, Biochemical pharmacology.

[19]  E. L. Prak,et al.  Developmental Acquisition of the Lyn-CD22-SHP-1 Inhibitory Pathway Promotes B Cell Tolerance1 , 2009, The Journal of Immunology.

[20]  I. Nishino,et al.  Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice. , 2009, Human molecular genetics.

[21]  A. Takamori,et al.  Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft. , 2008, Journal of vascular surgery.

[22]  Qingbo Xu,et al.  Proteomics Identifies Thymidine Phosphorylase As a Key Regulator of the Angiogenic Potential of Colony-Forming Units and Endothelial Progenitor Cell Cultures , 2008, Circulation research.

[23]  Woo Ick Yang,et al.  Angiogenic Factor Thymidine Phosphorylase Increases Cancer Cell Invasion Activity in Patients with Gastric Adenocarcinoma , 2008, Molecular Cancer Research.

[24]  R. Silverstein,et al.  A Specific CD36-Dependent Signaling Pathway Is Required for Platelet Activation by Oxidized Low-Density Lipoprotein , 2008, Circulation research.

[25]  K. McCrae,et al.  Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice. , 2008, The Journal of clinical investigation.

[26]  Kuniyoshi Tanaka,et al.  Long‐term effect of gene therapy for chronic ischemic myocardium using platelet‐derived endothelial cell growth factor in dogs , 2008, The journal of gene medicine.

[27]  S. Hazen,et al.  Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype , 2007, Nature Medicine.

[28]  Kuniyoshi Tanaka,et al.  Platelet-derived endothelial cell growth factor gene therapy for limb ischemia. , 2006, Journal of vascular surgery.

[29]  S. Kunapuli,et al.  G-protein-gated inwardly rectifying potassium channels regulate ADP-induced cPLA2 activity in platelets through Src family kinases. , 2006, Blood.

[30]  J. Balzarini,et al.  5′-O-Tritylated Nucleoside Derivatives: Inhibition of Thymidine Phosphorylase and Angiogenesis , 2006, Molecular Pharmacology.

[31]  J. Balzarini,et al.  Thymidine phosphorylase inhibitors: recent developments and potential therapeutic applications. , 2005, Mini reviews in medicinal chemistry.

[32]  Wei Li,et al.  Thymidine Phosphorylase Gene Transfer Inhibits Vascular Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1 and p27KIP1 , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[33]  T. Furukawa,et al.  The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression , 2004, Cancer science.

[34]  E. De Clercq,et al.  The Nucleoside Derivative 5′-O-Trityl-inosine (KIN59) Suppresses Thymidine Phosphorylase-triggered Angiogenesis via a Noncompetitive Mechanism of Action* , 2004, Journal of Biological Chemistry.

[35]  E. Schwartz,et al.  Expression of the angiogenic factor thymidine phosphorylase in THP-1 monocytes: induction by autocrine tumor necrosis factor-alpha and inhibition by aspirin. , 2003, Molecular pharmacology.

[36]  K. Hotchkiss,et al.  Thymidine Phosphorylase and 2-Deoxyribose Stimulate Human Endothelial Cell Migration by Specific Activation of the Integrins α5β1 and αVβ3* , 2003, Journal of Biological Chemistry.

[37]  M. Fukushima,et al.  Targeted Deletion of Both Thymidine Phosphorylase and Uridine Phosphorylase and Consequent Disorders in Mice , 2002, Molecular and Cellular Biology.

[38]  S. Watson,et al.  Association of Fyn and Lyn with the Proline-rich Domain of Glycoprotein VI Regulates Intracellular Signaling* , 2002, The Journal of Biological Chemistry.

[39]  T. Pestina,et al.  Role of the Src family kinase Lyn in TxA2 production, adenosine diphosphate secretion, Akt phosphorylation, and irreversible aggregation in platelets stimulated with gamma-thrombin. , 2002, Blood.

[40]  Y. Hayashi,et al.  Increased expression of platelet-derived endothelial cell growth factor in human hepatocellular carcinomas correlated with high Edmondson grades and portal vein tumor thrombosis. , 2001, Oncology reports.

[41]  S. Watson,et al.  Fyn and Lyn phosphorylate the Fc receptor gamma chain downstream of glycoprotein VI in murine platelets, and Lyn regulates a novel feedback pathway. , 2000, Blood.

[42]  P. Weissberg,et al.  Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis , 2000, The Journal of pathology.

[43]  C. Bon,et al.  Collagen, convulxin, and thrombin stimulate aggregation-independent tyrosine phosphorylation of CD31 in platelets. Evidence for the involvement of Src family kinases. , 2000, The Journal of biological chemistry.

[44]  W. Lim,et al.  Improving SH3 domain ligand selectivity using a non-natural scaffold. , 2000, Chemistry & biology.

[45]  E. Gharehbaghi-Schnell,et al.  Expression of the angiogenic protein, platelet-derived endothelial cell growth factor, in coronary atherosclerotic plaques: In vivo correlation of lesional microvessel density and constrictive vascular remodeling. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[46]  R. Hynes,et al.  Hemostasis in the Mouse (Mus musculus): A Review , 1999, Thrombosis and Haemostasis.

[47]  J. Cambier,et al.  Design and synthesis of SH3 domain binding ligands: modifications of the consensus sequence XPpXP. , 1998, Bioorganic & medicinal chemistry letters.

[48]  A. Jasanoff,et al.  Structural and theoretical studies suggest domain movement produces an active conformation of thymidine phosphorylase. , 1998, Journal of molecular biology.

[49]  K. O'Byrne,et al.  Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer. , 1997, British Journal of Cancer.

[50]  R. Bicknell,et al.  Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. , 1992, Biochemistry.

[51]  K. Miyazono,et al.  Purification and properties of an endothelial cell growth factor from human platelets. , 1987, The Journal of biological chemistry.

[52]  M. Germain,et al.  Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients. , 1977, Journal of the National Cancer Institute.

[53]  M. Friedkin,et al.  The enzymatic synthesis of nucleosides. II. Thymidine and related pyrimidine nucleosides. , 1954, The Journal of biological chemistry.

[54]  B. Bax,et al.  Preclinical toxicity evaluation of erythrocyte-encapsulated thymidine phosphorylase in BALB/c mice and beagle dogs: an enzyme-replacement therapy for mitochondrial neurogastrointestinal encephalomyopathy. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[55]  Huntingdon Lifesciences.  Preclinical toxicity evaluation of erythrocyte-encapsulated thymidine phosphorylase in BALB/c mice and Beagle dogs: an enzyme replacement therapy for mitochondrial neurogastrointestinal encephalomyopathy , 2012 .

[56]  N. Tandon,et al.  GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism. , 2006, Thrombosis research.

[57]  Y. Fujibayashi,et al.  Gene therapy for chronic myocardial ischemia using platelet-derived endothelial cell growth factor in dogs. , 2005, American journal of physiology. Heart and circulatory physiology.

[58]  K. Hotchkiss,et al.  Thymidine phosphorylase and 2-deoxyribose stimulate human endothelial cell migration by specific activation of the integrins alpha 5 beta 1 and alpha V beta 3. , 2003, The Journal of biological chemistry.